Naiel N. Nassar, MD, FACP

Infectious Diseases Staff Physician, Central California Faculty Medical Group, Fresno
Internal Medicine Faculty, UCSF Fresno

1984-1986  Ain Shams University Hospitals, Almaza Military Hospital 
1988-1991 St. Luke's/Roosevelt Hospital Center, Good Samaritan Hospital

1. Keiser P, Nassar N. Time to Virologic Failure With Atazanavir/Ritonavir and Lopinavir/Ritonavir, ± An H2-Receptor Blocker, Not Significantly Different in HIV Observational Database Study". Accepted, International Journal of STD & AIDS, Nov 10, 2007
2. Keiser P, Nassar N. Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection. Expert Opin Pharmacother. 2007 Mar;8(4):477-83
3. Keiser P, Nassar N, Yazdani B, Armas L and Moreno S. Comparison of Efficacy of Efavirenz and Nevirapine: Lessons learned for cohort analysis in light of the 2NN Study. HIV Clinical Trials. Sept-Oct  2003.: 358-360
4. Keiser P, Nassar N, White AC,  Koen G,  and Moreno S. Comparison of Nevirapine- and Efavirenz-Containing Antiretroviral Regimens in Antiretroviral-Naïve Patients: A Cohort Study.  HIV Clinical Trials; July- August 2002.
5. Keiser P and Nassar N. Trizivir .Expert Opin Pharmacother 2002:31-6
6. Keiser P, Kvanli ME, Turner D, Nassar N. Long-Term Impact of Highly Active Antiretroviral Therapy on HIV-Related Health Care Costs. J AIDS  2001;27:14-19
7. Keiser P, Nassar N, Skiest DJ, Rademacher S and Smith JW. The utility of ciprofloxin in the treatment of disseminated Mycobacterium avium infection. International J of STD & AIDS 10:791-794 2000
8. Keiser P, Kvanli ME, Turner D, Reich J, Smith JW, Nassar N, Gregg CG and Skiest DJ. Protease Inhibitors based therapy is associated with decreased HIV related hospital costs. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):28-33.
9. Nassar N, Gregg CR. Esophageal Infections. Current Treatment Options in Gastroenterology 1998, 1:56-63.
10. Gregg CR, Nassar N. Infectious Enteritis. Current Treatment Options in Gastroenterology 1999, 2:119-126.
11. Keiser P, Nassar N, Rademacher S, Smith JW. Clarithromycin containing regimens are superior to non-clarithromycin containing regimens in the treatment of disseminated Mycobacterium avium complex infection in patients with AIDS. (In Press).
12. Keiser P, Turner D, Ramilo O, Kvanli MB, Smith JW, Nassar N.  An open label, pilot study of the efficacy and tolerability of once daily versus twice daily didanosine. The efficacy and tolerability of once daily DDI in versus twice daily DDI in the treatment of HIV Infection. Clin Infect Dis 27:400-401 1998.
13. Nassar N, Keiser P, Gregg C. Keeping travelers healthy. Am J Med Sci 1998; 315(5): 327-36
14. Warren K, Kazi S, Nassar N. Gout in a patient with Reiter syndrome.  Cutis 1998; 61(2): 85-6.
15. Flynn N, Jain S, Keddie EM, Carlson JR, Jennings MB, Haverkos HW, Nassar N, Anderson R, Cohen S, Goldberg D. In vitro activity of readily available household materials against HIV-1: is bleach enough?. J Acquir Immune Defic Syndr 1994 Jul;7(7):747-53.
16. Hrdy D, Nassar N, Rinaldi M, Traumatic joint infection due to Geotrichum candidum, Clinical Infectious Disease 1995; 20: 2, 468.
17. Nassar N, Lawrence R.  Infectious Complications of AIDS. Consultant, February 1993
18. Nassar N. Coordinated Community Programs for HIV Prevention among Intravenous Drug Users. Morbidity and Mortality Weekly Report (MMWR) June 2, 1989, Vol. 38, No. 21.
    
    

Books

1. Nassar N, Keiser P, Gregg C. Pocket Guide to HIV Care 2006 (Spanish Language Updated Edition). SphinxMedicus Inc.
2. Nassar N, Keiser P, Gregg C. Pocket Guide to HIV Care 2005. SphinxMedicus Inc.
3. Nassar N, Skiest D, Keiser P. Parkland Pocket Guide to HIV Care 2001. SphinxMedicus Inc.
4. Nassar N, Smith JW.  Bacterial infections of the urinary tract in males. Conn’s Current Therapy, 2000 Rakel RE, Ed. WB Saunders Co.
5. Radolf JD. Nassar N. Nonvenereal Treponematosis: Yaws, Pinta, and Endemic Syphilis. Textbook of Internal Medicine, 4th edition, ed. W.N. Kelley, Lippincott-Raven, Philadelphia.
6. Radolf JD. Nassar N. Syphilis. Textbook of Internal Medicine, 4th edition, ed. W.N. Kelley, Lippincott-Raven, Philadelphia.
7. Nassar N, Skiest D, Gregg CR, Keiser P. Parkland Pocket Guide to HIV Care. SphinxMedicus Inc. 1998-1999. 
8. Nassar N, Radolf JD. Practice Points: “Management of a positive VDRL in HIV-infected pregnant woman from areas endemic for non-venereal treponematoses” in Infectious Diseases 1999.  Armstrong & Cohen Ed.  Mosby Inc.
9. Nassar N, Hasan MS, Gregg CR.  Infectious Diarrhea. Gastrointestinal Disease in Primary Care. 1999. Bilhartz LE, Croft C, Ed.  Williams & Wilkins.
10. Nassar N, Smith JW.  Bacterial infections of the urinary tract in males. Conn’s Current Therapy, 1999 Rakel RE, Ed. WB Saunders Co.
11. Nassar N, Skiest D, Keiser P. Parkland Pocket Guide to HIV Care. SphinxMedicus Inc. 1997.
12. Nassar N, Pocket Guide to HIV Care. Fifth Edition, March 1996, University of California, Davis.
13. Nassar N, Pocket Guide to HIV Care.  Fourth Edition, April 1995, University of California, Davis.
14. Nassar N, Pocket Guide to HIV Care. Third Edition, January 1994, UC Davis.
15. Nassar N. Pocket Guide to HIV Care. Second Edition, January 1993, UC Davis.
16. Nassar N. Pocket Guide to HIV Care. First Edition, May 1992, UC Davis.
    
    

Multimedia Presentations

1. Smith JW, Luby JP, Skiest DJ, Nassar N, Keiser P. “STD Update: the treatment of HIV infection” Video, University of Texas Southwestern Medical Center and the Dallas County Health Department 1997.
2. Nassar N, Mumps, PDxMD

Abstracts

1. P Keiser, N N Nassar, G Koen, S Moreno.  Comparison of virologic response in a cohort of women and men treated with Nelfinavir containing HAART regimens  14th  International AIDS Conference, Barcelona July 7-14, 2002 Abstract WePeB5962
2. Flynn NM, White C, Nassar N, Cohen SH. Prevalence of RT/PI Mutation in a Large HIV Clinic Population in an Urban Area. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco CA, 1999.
3. Keiser P, Nassar N, Kvanli ME, Turner D. Cost of HIV Care Increasing after an Initial Cost Decrease Associated with Protease Inhibitor Usage. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco CA, 1999
4. Osada K, Shimizu, M, Nassar, N.  Expression of chemokine receptors CCR5 and CXCR4 in peripheral blood of blood donors and HIV-positive patients by flow cytometry.  Abstract S142-P, Presented at the AABB 52nd annual meeting, San Francisco, November 1999.
5. Keiser P, Kvanli MB, Turner D, Smith JW, Nassar N, Gregg CR. Protease inhibitors, but not nucleoside analogues, are associated with decreased HIV related hospital costs.  Abstract. Fifth National Conference on Human Retroviruses and Related Infections, Chicago, IL, February 1998.
6. Nassar N, Gregg CR, Keiser P. Itraconazole in the treatment of onychomycosis. Abstract  (K47) for the 37th ICAAC, Toronto 1997.
7. Skiest D, Keiser P, Nassar N. Rapid changes in prescribing practices for individuals with HIV/AIDS: A survey of physicians attending the 1996 IDSA meeting. Abstract (469-HIV/AIDS: Epidemiology): for the 35th IDSA annual meeting, San Francisco.
8. Keiser P, Kvanli M, Turner D, Smith JW, Nassar N, Gregg CR.  Protease inhibitors are cost effective anti-HIV therapy. Abstract (469-HIV/AIDS: Antiretroviral therapy): for the 35th IDSA annual meeting, San Francisco.
9. Clarke S, Nassar N, Porter K., Trask S. An analysis of the use of antifungal drugs in an inpatient population. Abstract [RP-30]. for the American Society of Health-System Pharmacists meeting, December 1996, New Orleans, Louisiana.
10. Skiest D, Keiser P, Nassar N. A Survey of IDSA Meeting Attendees Prescribing Practices for Individuals with HIV/AIDS. Abstract. The 34th meeting for the IDSA, New Orleans 1996.
11. Nassar N, Rademacher S, Keiser P. Improved survival in disseminated MAC treated with clarithromycin containing regimens.  Abstract [Th.B.4311] for the XIth International Conference On AIDS in affiliation with the IVth STD World Congress, July 1996, Vancouver, Canada.
12. Anderson R, Flynn N, Britton J, Ascher M, Nassar N. On the street HIV testing and interviews of injecting drug users using finger stick antibody tests.  Abstract PO-C29-3261, for the IXth International Conference On AIDS in affiliation with  the IVth STD World Congress, Berlin, June 7-11, 1993
13. Flynn NM, Anderson R, Britton J, Ascher M, Nassar N, et al. Major differences in HIV seroprevalence between in-treatment and out-of-treatment injection drug users.  Abstract for the IXth International Conference on AIDS, Berlin, June 7-11, in affiliation with the IVth STD World Congress.
14. Nassar N. Prevention of HIV Infection in IV Drug Users in an Area of Low Prevalence: A Comprehensive Approach.  Abstract.  International Conference on AIDS, Book 2, Stockholm, Sweden, June 12-16, 1989
15. Nassar N. The "County Hospital": Major Partner in AIDS Education-Prevention VS Missed Opportunity.  Abstract.  IV International Conference on AIDS, Stockholm, Sweden, June 12-16, 1989.
16. Nassar N.  Can HIV Transmission among IVDU Be Slowed?  Poster presentation made to the University  of California, AIDS Task Force Conference of San Diego, California, March, 1988.

Apply/Contacts